In line with our observation of lower placental ceramide levels in both types of pre-gestational diabetes, immunoblotting for ASAH1, the enzyme that breaks down ceramide to sphingosine, revealed significantly greater levels of this enzyme in both T1D and T2D (Figure 1D), compared to control pregnancies. Here, ASAH1 is linked to gestational diabetes.